Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07347418
What this trial is testing

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

Who this might be right for
Refractory Acute Myeloid Leukemia (AML)Relapsed Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome+1 more
University of Colorado, Denver 23
Early research (Phase 1)Study completedNCT06562985
What this trial is testing

Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Who this might be right for
Acute Venous and Arterial Thrombotic and Thromboembolic EventsHealthy Volunteers
Bayer 39
Early research (Phase 1)Study completedNCT00756249
What this trial is testing

Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
H. Lundbeck A/S 16
Early research (Phase 1)Study completedNCT03179878
What this trial is testing

Safety and Tolerability of SYNB1020-CP-001

Who this might be right for
Healthy VolunteerUrea Cycle Disorder
Synlogic 52
Early research (Phase 1)Study completedNCT02151617
What this trial is testing

A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649

Who this might be right for
Healthy
Pfizer 40
Early research (Phase 1)Looking for participantsNCT07755397
What this trial is testing

First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

Who this might be right for
NSCLC Patients With EGFR Activating MutationAdenoid Cystic Carcinoma MetastaticAdenoid Cystic Carcinoma of the Head and Neck
Jubilant Therapeutics India Limited 30
Early research (Phase 1)Looking for participantsNCT06538558
What this trial is testing

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

Who this might be right for
Opioid Use Disorder
Proniras Corporation 40
Early research (Phase 1)Looking for participantsNCT05772455
What this trial is testing

XZB-0004 in Patients With Solid Tumors

Who this might be right for
Advanced Solid TumorNSCLC
Xuanzhu Biopharmaceutical Co., Ltd. 128
Early research (Phase 1)Study completedNCT03514615
What this trial is testing

A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers.

Who this might be right for
Scarring
University Hospitals, Leicester 45
Early research (Phase 1)Study completedNCT01515358
What this trial is testing

Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 18
Testing effectiveness (Phase 2)Study completedNCT02014558
What this trial is testing

Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 265
Early research (Phase 1)Study completedNCT00361855
What this trial is testing

Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle

Who this might be right for
Myocardial Infarction
Neuronyx 18
Early research (Phase 1)Looking for participantsNCT07568678
What this trial is testing

A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hua Medicine Limited 40
Post-approval studies (Phase 4)Study completedNCT03635125
What this trial is testing

Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine

Who this might be right for
JNC 7 Stage 1 or 2 Hypertension
Trinity Hypertension & Metabolic Research Institute 40
Early research (Phase 1)WithdrawnNCT05692908
What this trial is testing

An Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Sorrento Therapeutics, Inc.
Early research (Phase 1)Study completedNCT00047762
What this trial is testing

Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Genentech, Inc.
Early research (Phase 1)Ended earlyNCT02837991
What this trial is testing

A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)Clear-cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more
Celldex Therapeutics 16
Testing effectiveness (Phase 2)WithdrawnNCT01007461
What this trial is testing

IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial Infarction

Who this might be right for
ST-Segment Elevation Myocardial Infraction
Mallinckrodt
Testing effectiveness (Phase 2)Study completedNCT00888446
What this trial is testing

Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid

Who this might be right for
Human Immunodeficiency Virus InfectionsHIV Infections
International AIDS Vaccine Initiative 91
Early research (Phase 1)Study completedNCT00345670
What this trial is testing

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Who this might be right for
Healthy
MedImmune LLC 120
Next Page